Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Oncology (6)
- Diseases (5)
- Hemic and Lymphatic Diseases (4)
- Medical Sciences (3)
- Public Health (3)
-
- Medical Pathology (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- COVID-19 (1)
- Cardiology (1)
- Chemical and Pharmacologic Phenomena (1)
- Health Services Administration (1)
- Health Services Research (1)
- Immunology and Infectious Disease (1)
- Immunotherapy (1)
- Internal Medicine (1)
- Life Sciences (1)
- Medical Molecular Biology (1)
- Neoplasms (1)
- Nephrology (1)
- Obstetrics and Gynecology (1)
- Pathology (1)
- Physiotherapy (1)
- Rehabilitation and Therapy (1)
- Surgery (1)
- Therapeutics (1)
- Translational Medical Research (1)
- Keyword
-
- Humans (19)
- Adult (9)
- Anemia (8)
- Anemia, Sickle Cell (7)
- Female (7)
-
- Male (7)
- Lymphoma (6)
- Middle Aged (5)
- Middle aged (5)
- Retrospective Studies (4)
- Sickle cell (4)
- Thrombosis (4)
- Treatment Outcome (4)
- Animals (3)
- Local (3)
- Lymphoma, B-Cell, Marginal Zone (3)
- Neoplasm Recurrence, Local (3)
- Retrospective studies (3)
- Sickle Cell (3)
- Treatment outcome (3)
- Aged (2)
- B-cell (2)
- Blood Platelets (2)
- Chronic Pain (2)
- Chronic pain (2)
- Hemostatics (2)
- Marginal zone (2)
- Mice (2)
- Neoplasm recurrence (2)
- Pain (2)
- Publication Year
Articles 31 - 31 of 31
Full-Text Articles in Hematology
Drugs For Preventing Red Blood Cell Dehydration In People With Sickle Cell Disease., Srikanth Nagalla, Samir K Ballas
Drugs For Preventing Red Blood Cell Dehydration In People With Sickle Cell Disease., Srikanth Nagalla, Samir K Ballas
Department of Medicine Faculty Papers
BACKGROUND: Sickle cell disease is an inherited disorder of hemoglobin, resulting in abnormal red blood cells. These are rigid and may block blood vessels leading to acute painful crises and other complications. Recent research has focused on therapies to rehydrate the sickled cells by reducing the loss of water and ions from them. Little is known about the effectiveness and safety of such drugs.
OBJECTIVES: To assess the relative risks and benefits of drugs to rehydrate sickled red blood cells.
SEARCH METHODS: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register.Last search of the Group's Trials …